Agents such as benzodiazepines, sedative-hypnotics, antihypertensives, and other psychoactive drugs—often used to treat comorbidities in patients with COPD—may be contributing to an increased risk of falls among this population near the end of life.
"Medicare beneficiaries who undergo EBV present with fewer comorbidities, but after risk adjustment they have higher mortality and procedure-related morbidity than those undergoing LVRS," finds study of 3,219 patients comparing contemporary surgical outcomes.
New research demonstrates cardiovascular health metrics inversely correlate with COPD risk, with high LE8 scores associated with 82% lower disease prevalence in adults older than age 40.
Large-scale study of 1.9M veterans identifies previously unreported benefits and risks of GLP-1 receptor agonists across 175 health outcomes, including reduced substance use disorders and increased pancreatitis risk.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The US Food and Drug Administration has introduced a proposal to cap nicotine levels in cigarettes, with the goal of curbing addiction, reducing smoking rates, and averting millions of tobacco-related deaths by 2100.